Sponsored by
 |
Wednesday, October 22
1-1:50pm
Location: Galileo 903
Chirositol™: A Breakthrough Ingredient for use in Blood Sugar and Lipid Management
The administration of D-chiro-inositol (DCI) to diabetic mammals (humans and animals) decreases elevated blood glucose and lipid levels. D-Chiro-Inositol (DCI) also acts as an anti-oxidant reducing reactive oxygen species (ROS), improving blood vessel health and maintaining nitric oxide (NO) signaling. DCI when administered in combination with manganese chloride was found to reduce more effectively elevated plasma glucose in diabetic rats. Dr. Joseph Larner, the discoverer of D-Chiro-Inositol, will be reviewing the science behind this unique nutraceutical ingredient.
Speaker: Joseph Larner, M.D., Ph.D. (Biochemistry), Chairman, Department of Pharmacology, University of Virginia School of Medicine (Ret.), Director of University Diabetes Research and Training Center
|
